European universities fail to report results for 83% of trials by Nick Paul Taylor Tuesday, April 30, 2019 The vast majority of universities are failing to comply with EU rules on the reporting of clinical trial results.
Neuron discovery could yield new treatments for hearing loss by Amirah Al Idrus Thursday, September 13, 2018 Swedish scientists have characterized a heterogeneous group of neurons in the inner ear, which could inspire new treatments for hearing loss.
Redmile, GV power exosome specialist Evox to £36M round by Nick Paul Taylor Tuesday, September 4, 2018 The series B, which attracted the support of GV, sets Evox up to take rare disease candidates into the clinic.
2 studies show CRISPR might drive up cancer risk in edited cells by Amirah Al Idrus Tuesday, June 12, 2018 Two new studies show that CRISPR editing could raise the risk of edited cells developing tumors.
Switching off enzymes to block cell division in cancer by Amirah Al Idrus Thursday, January 18, 2018 European researchers discovered how drugs bind to the enzyme DHODH, which could lead to more selective cancer drugs.
Protecting preemies with spider silk by Arlene Weintraub Thursday, May 25, 2017 The key to strengthening the lungs of premature babies may be held by spiders—namely, the way they spin their webs.
NeuroVive pipeline rebuild continues with Karolinska pact by Nick Paul Taylor Tuesday, January 10, 2017 NeuroVive Pharmaceutical has entered into a research collaboration with Karolinska Institutet.
International team IDs genes determining risk for cardiometabolic disease by Amirah Al Idrus Wednesday, August 24, 2016 A group of scientists has unlocked the interaction between genes in certain tissues that can play a role in the hereditary risk for cardiometabolic diseases, including conditions that can lead to heart attack and stroke.
